Institutional Ownership
Aardvark Therapeutics Inc
CUSIP 002942100COMAARDQ1 2026
Institutional Holders
75
13F filers
Shares Held
9.48M
Aggregate institutional
Institutional Value
$35.64M
Q1 2026
Net New Holders
+11
28 new · 17 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions28
Increased17
Decreased23
Sold out17
Institutional Holders
75 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Decheng Capital LLC | 3.92M | $14.77M | 0 | Held |
| 2 | Citadel Advisors LLC | 1.24M | $4.69M | −46.5K | Reduced |
| 3 | Laurion Capital Management LP | 1.03M | $3.90M | +19.5K | Added |
| 4 | Blackrock, Inc. | 792.6K | $2.99M | +8.1K | Added |
| 5 | Tetragon Partners Gp Ltd | 316.6K | $1.19M | +316.6K | New |
| 6 | Geode Capital Management, LLC | 309.4K | $1.17M | +11.6K | Added |
| 7 | Adage Capital Partners Gp, L.L.C. | 300.0K | $1.13M | +300.0K | New |
| 8 | State Street Corp | 199.3K | $751.4K | +41.1K | Added |
| 9 | Two Sigma Investments, LP | 163.4K | $615.8K | +34.6K | Added |
| 10 | Ubs Group AG | 157.9K | $595.2K | +131.1K | Added |
65 more institutional holders on Premium
See every fund holding Aardvark Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders